Advy

Advy is a global manufacturer of products expanding beyond Native Human Antigens (Purified Proteins) and Polyclonal Antibodies. The company's offerings include Diagnostic kits with Rapid Diagnostic Tests, Slide & TurbiLatex reagents, and customized quality products delivered to IVD manufacturers and suppliers worldwide. Consistently high quality, reproducible results, and a flexible approach to address the needs of each customer have helped Advy become the provider of choice to IVD manufacturers worldwide. With exports to the USA, Europe, Japan, and China, Advy has also entered the Indian market since 2010. Advy is a leader in the global market for the production of C Reactive Protein – an inflammatory biomarker, Alpha 1-microglobulin – a renal biomarker, and a wide range of polyclonal antibody products. Additionally, the company has the necessary expertise to manufacture diagnostic test kits, including Malaria Antigen Rapid Tests and Dengue Rapid Diagnostic Tests. The Advy facility is compliant with EN ISO 13485 and GMP manufacturing practices. Founded in 1989, Advy has established a successful reputation and a growing base of experiential knowledge, enabling its expansion into multiple global markets. Despite the absence of specific details on industries and headquarters, Advy's commitment to quality and its broad product range position it as an attractive prospect for investment. In summary, Advy's diverse product portfolio, global presence, and adherence to international quality standards make it a noteworthy player in the IVD manufacturing industry, presenting potential opportunities for strategic partnerships and investors seeking exposure to this sector.